Soumettre la recherche
Mettre en ligne
Eli lilly ranbaxy jv
•
3 j'aime
•
2,806 vues
R
Rajendra Inani
Suivre
Signaler
Partager
Signaler
Partager
1 sur 6
Recommandé
e
Eli lilly ranbaxy case group 4
Eli lilly ranbaxy case group 4
Ashish Thakur
Eli Lilly-Ranbaxy Alliance
Eli Lilly-Ranbaxy Alliance
Karan Jaidka
Eli Lilly and Company, Inc. Adani Institute of Infrastructure Management Case Analysis
Eli Lilly and Company, Inc. Case Analysis
Eli Lilly and Company, Inc. Case Analysis
Neeraj Mehra, CFA
Case study analysis
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
Mohammad Mohtashim
Markstrat ppt
Markstrat ppt
Swayambhar Majumder
MBA case study about the Silvio Napoli and his mission to establish Schindler's subsidiary in India.
Silvio Napoli at Schindler India-HBS Case Study
Silvio Napoli at Schindler India-HBS Case Study
Rawad Mroueh
By Mahadeo Nalawade For EMBA at Swis Business School
Eli Lilly Global Strategy
Eli Lilly Global Strategy
guest90d5a
itc ppt with bcg matrix
Itc bcg matrix
Itc bcg matrix
nehapunjabi26
Recommandé
e
Eli lilly ranbaxy case group 4
Eli lilly ranbaxy case group 4
Ashish Thakur
Eli Lilly-Ranbaxy Alliance
Eli Lilly-Ranbaxy Alliance
Karan Jaidka
Eli Lilly and Company, Inc. Adani Institute of Infrastructure Management Case Analysis
Eli Lilly and Company, Inc. Case Analysis
Eli Lilly and Company, Inc. Case Analysis
Neeraj Mehra, CFA
Case study analysis
Eli Lilly and company - Drug Development Strategy
Eli Lilly and company - Drug Development Strategy
Mohammad Mohtashim
Markstrat ppt
Markstrat ppt
Swayambhar Majumder
MBA case study about the Silvio Napoli and his mission to establish Schindler's subsidiary in India.
Silvio Napoli at Schindler India-HBS Case Study
Silvio Napoli at Schindler India-HBS Case Study
Rawad Mroueh
By Mahadeo Nalawade For EMBA at Swis Business School
Eli Lilly Global Strategy
Eli Lilly Global Strategy
guest90d5a
itc ppt with bcg matrix
Itc bcg matrix
Itc bcg matrix
nehapunjabi26
Achal Raghavan's case analysis (along with those from other authors) published in Vikalpa (the IIM Ahmedabad journal) in Oct-Dec 2007. Deals with the challenges faced by Infosys in transitioning from low-end system maintenance jobs to high-end consulting / solutions projects. The analysis includes a strategy recommendation. Though published several years back, the analysis is especially relevant now, when the "Infosys 3.0" growth strategy is under increasing scrutiny.
Infosys growth strategy - a case analysis
Infosys growth strategy - a case analysis
Achal Raghavan
Strategic Management Case with answers to case questions
ALDI: The Dark horse Discounter
ALDI: The Dark horse Discounter
Sinchan Pathak
Nucor Case Anlaysis
Nucor Case Anlaysis
Kaushambi Ghosh
Case Analysis Generic Versus Drug Discovery
Cipla Global Ltd.
Cipla Global Ltd.
Ogilvy & Mather
Cooperate owl by mayank and astha
case study analysis hp and compaq
case study analysis hp and compaq
Mayank Garg
Pharma supply chain demystified
Indias pharma supply chain
Indias pharma supply chain
Tanmay Gupta
HUL strategy management
Strategic Business Management Project Report on HUL
Strategic Business Management Project Report on HUL
Subhashish Mondal
cola wars case presentation
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
Rohail Siddique
Wal-Mart Stores in 2003 (HBS Case 9-704-430) Strategy Management PGDM Case Study
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Aditya Jhunjhunuwala
Presentation on Barilla Spa Case: An HBR Case presented in class in XLRI Jamshedpur (GMP)
Barilla Spa: A case on Supply Chain Integration
Barilla Spa: A case on Supply Chain Integration
Himadri Singha
Biocon India Case Study
Biocon case study group 1
Biocon case study group 1
ANURAG GUPTA
Marketing/Business Development
Pharmaceutical Porter analysis
Pharmaceutical Porter analysis
Pharm Net
A case study on Newell
Case study- Newell
Case study- Newell
tanveerahmed336
Vinsun infra engineering: Case on ERP
Vinsun infra engineering: Case on ERP
Himanshu Arora
Company and Industry Analysis of Cipla Ltd. including SWOT, PORTER and PESTLE analysis
Cipla Presentation
Cipla Presentation
Kartik Maniktala
solution of case study
Ranbaxy and daiichi case study
Ranbaxy and daiichi case study
Priyanka Jain
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical Industry
Yee Jie NG
Silvio Napoli @ Schinder India
Silvio Napoli at Schinder India
Silvio Napoli at Schinder India
Ravitheja Oleti
PESTEL Study
Schindler case study
Schindler case study
Rajesh Srivastava
Signode case study
Signode case study
Santosh Diwakar
Ranbaxy global strategy for growth
Ranbaxy global strategy for growth
Virendra Shukla
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta. The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in India
MadhuraNewrekar
Contenu connexe
Tendances
Achal Raghavan's case analysis (along with those from other authors) published in Vikalpa (the IIM Ahmedabad journal) in Oct-Dec 2007. Deals with the challenges faced by Infosys in transitioning from low-end system maintenance jobs to high-end consulting / solutions projects. The analysis includes a strategy recommendation. Though published several years back, the analysis is especially relevant now, when the "Infosys 3.0" growth strategy is under increasing scrutiny.
Infosys growth strategy - a case analysis
Infosys growth strategy - a case analysis
Achal Raghavan
Strategic Management Case with answers to case questions
ALDI: The Dark horse Discounter
ALDI: The Dark horse Discounter
Sinchan Pathak
Nucor Case Anlaysis
Nucor Case Anlaysis
Kaushambi Ghosh
Case Analysis Generic Versus Drug Discovery
Cipla Global Ltd.
Cipla Global Ltd.
Ogilvy & Mather
Cooperate owl by mayank and astha
case study analysis hp and compaq
case study analysis hp and compaq
Mayank Garg
Pharma supply chain demystified
Indias pharma supply chain
Indias pharma supply chain
Tanmay Gupta
HUL strategy management
Strategic Business Management Project Report on HUL
Strategic Business Management Project Report on HUL
Subhashish Mondal
cola wars case presentation
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
Rohail Siddique
Wal-Mart Stores in 2003 (HBS Case 9-704-430) Strategy Management PGDM Case Study
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Aditya Jhunjhunuwala
Presentation on Barilla Spa Case: An HBR Case presented in class in XLRI Jamshedpur (GMP)
Barilla Spa: A case on Supply Chain Integration
Barilla Spa: A case on Supply Chain Integration
Himadri Singha
Biocon India Case Study
Biocon case study group 1
Biocon case study group 1
ANURAG GUPTA
Marketing/Business Development
Pharmaceutical Porter analysis
Pharmaceutical Porter analysis
Pharm Net
A case study on Newell
Case study- Newell
Case study- Newell
tanveerahmed336
Vinsun infra engineering: Case on ERP
Vinsun infra engineering: Case on ERP
Himanshu Arora
Company and Industry Analysis of Cipla Ltd. including SWOT, PORTER and PESTLE analysis
Cipla Presentation
Cipla Presentation
Kartik Maniktala
solution of case study
Ranbaxy and daiichi case study
Ranbaxy and daiichi case study
Priyanka Jain
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical Industry
Yee Jie NG
Silvio Napoli @ Schinder India
Silvio Napoli at Schinder India
Silvio Napoli at Schinder India
Ravitheja Oleti
PESTEL Study
Schindler case study
Schindler case study
Rajesh Srivastava
Signode case study
Signode case study
Santosh Diwakar
Tendances
(20)
Infosys growth strategy - a case analysis
Infosys growth strategy - a case analysis
ALDI: The Dark horse Discounter
ALDI: The Dark horse Discounter
Nucor Case Anlaysis
Nucor Case Anlaysis
Cipla Global Ltd.
Cipla Global Ltd.
case study analysis hp and compaq
case study analysis hp and compaq
Indias pharma supply chain
Indias pharma supply chain
Strategic Business Management Project Report on HUL
Strategic Business Management Project Report on HUL
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
cola-wars-continue-coke-and-pepsi-in-2006-by-group-c
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Wal-Mart Stores in 2003 (HBS Case 9-704-430)
Barilla Spa: A case on Supply Chain Integration
Barilla Spa: A case on Supply Chain Integration
Biocon case study group 1
Biocon case study group 1
Pharmaceutical Porter analysis
Pharmaceutical Porter analysis
Case study- Newell
Case study- Newell
Vinsun infra engineering: Case on ERP
Vinsun infra engineering: Case on ERP
Cipla Presentation
Cipla Presentation
Ranbaxy and daiichi case study
Ranbaxy and daiichi case study
Competitive Analysis in Pharmaceutical Industry
Competitive Analysis in Pharmaceutical Industry
Silvio Napoli at Schinder India
Silvio Napoli at Schinder India
Schindler case study
Schindler case study
Signode case study
Signode case study
Similaire à Eli lilly ranbaxy jv
Ranbaxy global strategy for growth
Ranbaxy global strategy for growth
Virendra Shukla
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta. The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in India
MadhuraNewrekar
Pharmaceutical industry in india
Pharmaceutical industry in india
Sahil Khanna
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company. Case study presented me and my colleagues.
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
Atul Prajapati
Ranbaxy
Ranbaxy
Aniruddha Nayak
small ppt. on pharma indstry.
Pharma
Pharma
nisha192
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
sridivyaannavarapu
Ranbaxycompanyprofile
Ranbaxycompanyprofile
bhawna allagh
Pharmaceutical industry-in-india
Pharmaceutical industry-in-india
Pharmaceutical industry-in-india
Chandresh M
ranbaxy company profile.
Ranbaxy
Ranbaxy
Rohit Choudhary
Overview of the Pharma industry
Overview of the Pharma industry
keyursavalia
pharmaceuctical industry booming in India.
Pharmaceutical industry in India
Pharmaceutical industry in India
Shireen Bobade
A Case Study Presentation on "Dr. Reddie's Laboratories" Done By, 1) Lekha Prasad 2) Lekshmi Vijayakumar 3) Jubin Varghese 4) Joel Sabu 5) Jyothi Vijayan Students of 2015-2017 MBA Batch MACFAST College Thiruvalla, Kerala
Strategic Management Group Presentation
Strategic Management Group Presentation
JOEL SABU
Aarti Drugs Limited (ADL), incorporated in 1984 is part of Rs 3,000 crore Aarti Group of Industries and is engaged in manufacturing and sale of Active pharmaceutical ingredients (APIs), advanced intermediates and specialty chemicals. ADL manufactures drugs in therapeutic segments such as anti-arthritis, anti-fungal, antibiotics, anti-diabetic, sedatives, anti-depressant, anti-diarrhea and anti-inflammatory. In Aarti Drugs we get a bulk drugs manufacturer with steady growth across the years, continuously improving performance on various financial parameters, good dividend yield of more than 5% and low valuations of 5 times earnings and EV/EBIT of 5.28. Besides, what instills further confidence in the stock is the fact that promoters of the company have been continuously increasing their stake with regular purchases from open market. Two years back promoters had 54.83% stake in the company and the same now stands increased to 59.65%.
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Katalyst Wealth
seminar
seminar
Depika Battu
Key Topics Covered 1. Uniform Code on Sales and Marketing Practices in India 2. Issuance of warning letters to Indian facilities by USFDA: not a concern 3. Biosimilar perspective for Indian market 4. New drug discovery development in India 5. Biocon: Sits comfortable with its near and long term contributory products 6. Cadila Healthcare: NCE, Transdermal, Biosimilars and Complex generics launches thru 2016 –Eventful time ahead 7. Cipla: Major change in business model 8. Dr. Reddy’s Lab: Focus on Complex formulations and Biogenerics to intensify 9. Glenmark: US business, NCE and ParaIV will show significant growth 10. IPCA: Fine chemicals to formulation –Global leadership in select products 11. Lupin: US and Japan Business –Key for long term growth 12. Natco: Leveraging chemistry, formulation and IP strength –For Us and India Markets 13. Panacea Biotec: Financial trouble mounting, Acceptance of WHO prequalification and formulation business will revive the company 14. Shasun: On path to become fully integrated Pharma company 15. Shilpa Medicare: A leader in Oncology API, Expanding into Non-Onco, peptides and complex formulations 16. Sun Pharma: Strong Management Team - Absolute and Comparative Advantage
Indian companies are taking center stage in Complex Generics at US and EU mar...
Indian companies are taking center stage in Complex Generics at US and EU mar...
mpadvisors
Pharmaceuticals Industry Analysis with analysis of Top notch Companies in pharmaceuticals viz. Sun pharma, Lupin, Dr. Reddy's Laboratory, Cipla, Aurobindo Pharma to identify opportunity to invest in equity share of these companies.
Study On Pharmaceuticals Companies
Study On Pharmaceuticals Companies
Varsha Chauhan
ENTERPRISE ANALYSIS OF LUPIN PHARMA
LUPIN PPT.pptx
LUPIN PPT.pptx
RushikeshPawade1
jsdgwytqwe
Rishabh presentation.pptx
Rishabh presentation.pptx
Rishabh Mishra
Sun Pharma Advance Research Company Limited (SPARC) is a leading pharmaceutical R&D company. This presentation is based on the solution faced by the company for last couple of years.
Sun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited Presentation
Subhashish Mondal
Similaire à Eli lilly ranbaxy jv
(20)
Ranbaxy global strategy for growth
Ranbaxy global strategy for growth
Present Status and Scope of Pharmaceutical industry in India
Present Status and Scope of Pharmaceutical industry in India
Pharmaceutical industry in india
Pharmaceutical industry in india
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
Ranbaxy
Ranbaxy
Pharma
Pharma
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
Ranbaxycompanyprofile
Ranbaxycompanyprofile
Pharmaceutical industry-in-india
Pharmaceutical industry-in-india
Ranbaxy
Ranbaxy
Overview of the Pharma industry
Overview of the Pharma industry
Pharmaceutical industry in India
Pharmaceutical industry in India
Strategic Management Group Presentation
Strategic Management Group Presentation
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
Aarti Drugs Ltd (NSE Code - AARTIDRUGS) - Feb'14 Katalyst Wealth Alpha Recomm...
seminar
seminar
Indian companies are taking center stage in Complex Generics at US and EU mar...
Indian companies are taking center stage in Complex Generics at US and EU mar...
Study On Pharmaceuticals Companies
Study On Pharmaceuticals Companies
LUPIN PPT.pptx
LUPIN PPT.pptx
Rishabh presentation.pptx
Rishabh presentation.pptx
Sun Pharma Advance Research Company Limited Presentation
Sun Pharma Advance Research Company Limited Presentation
Plus de Rajendra Inani
Dcv iimiccdvsallocfinal
Dcv iimiccdvsallocfinal
Rajendra Inani
Trans share inc - case study submission 12 sep 09 v1.1
Trans share inc - case study submission 12 sep 09 v1.1
Rajendra Inani
Msrdc case study
Msrdc case study
Rajendra Inani
Merrimack tractors analysis - final
Merrimack tractors analysis - final
Rajendra Inani
Maharashtra state road development corporation
Maharashtra state road development corporation
Rajendra Inani
Group 8 epgp - meeting management - communication presentation
Group 8 epgp - meeting management - communication presentation
Rajendra Inani
Fra coca - cola case study
Fra coca - cola case study
Rajendra Inani
Explore indore rajendra inani
Explore indore rajendra inani
Rajendra Inani
Epgp bm brand_extensions_ppt
Epgp bm brand_extensions_ppt
Rajendra Inani
Epgp(one year) 2009-10_fsr_group4_03.12.09
Epgp(one year) 2009-10_fsr_group4_03.12.09
Rajendra Inani
Epgp term v mos group assignment april 2010
Epgp term v mos group assignment april 2010
Rajendra Inani
Epgp (one year) 2009-dell assignment_#1_19jan10
Epgp (one year) 2009-dell assignment_#1_19jan10
Rajendra Inani
Epgp (one year) 2009-10_mos_ assignment_#1_18jan10
Epgp (one year) 2009-10_mos_ assignment_#1_18jan10
Rajendra Inani
Epgp (one year) 2009-10_mos_ assignment_#1_5jan10
Epgp (one year) 2009-10_mos_ assignment_#1_5jan10
Rajendra Inani
Epgp (one year) 2009-10_cost management_group assignement_case i_25nov09
Epgp (one year) 2009-10_cost management_group assignement_case i_25nov09
Rajendra Inani
Epgp (one year) 2009-10_cf_ assignment_#4_19jan10
Epgp (one year) 2009-10_cf_ assignment_#4_19jan10
Rajendra Inani
Epgp (one year) 2009-10_cf_ assignment_#3_14jan10
Epgp (one year) 2009-10_cf_ assignment_#3_14jan10
Rajendra Inani
Epgp (one year) 2009-10_cf_ assignment_#2_6jan10
Epgp (one year) 2009-10_cf_ assignment_#2_6jan10
Rajendra Inani
Epgp 09 10 -fra term 1 - end term submission - rajendra inani
Epgp 09 10 -fra term 1 - end term submission - rajendra inani
Rajendra Inani
Epgp 09 10 -cfl project - term 1 - group viii
Epgp 09 10 -cfl project - term 1 - group viii
Rajendra Inani
Plus de Rajendra Inani
(20)
Dcv iimiccdvsallocfinal
Dcv iimiccdvsallocfinal
Trans share inc - case study submission 12 sep 09 v1.1
Trans share inc - case study submission 12 sep 09 v1.1
Msrdc case study
Msrdc case study
Merrimack tractors analysis - final
Merrimack tractors analysis - final
Maharashtra state road development corporation
Maharashtra state road development corporation
Group 8 epgp - meeting management - communication presentation
Group 8 epgp - meeting management - communication presentation
Fra coca - cola case study
Fra coca - cola case study
Explore indore rajendra inani
Explore indore rajendra inani
Epgp bm brand_extensions_ppt
Epgp bm brand_extensions_ppt
Epgp(one year) 2009-10_fsr_group4_03.12.09
Epgp(one year) 2009-10_fsr_group4_03.12.09
Epgp term v mos group assignment april 2010
Epgp term v mos group assignment april 2010
Epgp (one year) 2009-dell assignment_#1_19jan10
Epgp (one year) 2009-dell assignment_#1_19jan10
Epgp (one year) 2009-10_mos_ assignment_#1_18jan10
Epgp (one year) 2009-10_mos_ assignment_#1_18jan10
Epgp (one year) 2009-10_mos_ assignment_#1_5jan10
Epgp (one year) 2009-10_mos_ assignment_#1_5jan10
Epgp (one year) 2009-10_cost management_group assignement_case i_25nov09
Epgp (one year) 2009-10_cost management_group assignement_case i_25nov09
Epgp (one year) 2009-10_cf_ assignment_#4_19jan10
Epgp (one year) 2009-10_cf_ assignment_#4_19jan10
Epgp (one year) 2009-10_cf_ assignment_#3_14jan10
Epgp (one year) 2009-10_cf_ assignment_#3_14jan10
Epgp (one year) 2009-10_cf_ assignment_#2_6jan10
Epgp (one year) 2009-10_cf_ assignment_#2_6jan10
Epgp 09 10 -fra term 1 - end term submission - rajendra inani
Epgp 09 10 -fra term 1 - end term submission - rajendra inani
Epgp 09 10 -cfl project - term 1 - group viii
Epgp 09 10 -cfl project - term 1 - group viii
Eli lilly ranbaxy jv
1.
2.
3.
4.
5.
6.
![Global Pharma Companies in 1990s ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](https://image.slidesharecdn.com/elilillyranbaxyjv-100718093917-phpapp01/85/Eli-lilly-ranbaxy-jv-1-320.jpg)
![Indian Pharma Industries in 1990s ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)